Poly Medicure appoints Indranil Mukherjee as CEO, Asia Pacific and India

Poly Medicure, India’s leading medical device company with a dominant position in the medical consumables market, today announced the appointment of Indranil Mukherjee as Chief Executive Officer, Asia Pacific and India, effective 1 June 2026.

The appointment comes at a pivotal stage in Poly Medicure’s growth journey as the company continues to strengthen its position as a leading global medical device manufacturer. With a growing international footprint, strategic acquisitions, expanding manufacturing capabilities, and a strong focus on innovation-led growth, Poly Medicure is broadening its presence across key markets and advancing its portfolio of high-value medical devices and healthcare solutions.

Based in India, Indranil will lead Poly Medicure’s operations across India and the Asia Pacific region, with responsibility for driving commercial growth, deepening market penetration, strengthening strategic partnerships, and supporting the company’s long-term expansion objectives.

Indranil is a seasoned medical technology executive with over 30 years of broad-based leadership experience spanning critical care, infusion therapy, renal care, surgical instruments, vascular systems, wound care, and implantable devices. He has demonstrated track record of acting as a change agent, scaling up business and leading market expansion, M&A and integration, organisational restructuring, and strategy execution. He combines deep industry insight with data-driven decision-making to deliver sustainable business outcomes.

He built the foundational years of his career at B. Braun, where he managed the company’s portfolios across India, before being transferred to B. Braun’s headquarters in Germany as Global Sales Manager in 2010 and subsequently serving as Regional Head for Hospital Care at the Asia Pacific headquarters in Penang, Malaysia. In his role as Managing Director at B. Braun Group in India, he delivered a turnaround and sustained profitable growth across multiple product lines spanning three manufacturing plants and a team of over 2,000 colleagues. He later served as Group Chief Executive Officer of Translumina Therapeutics, a global cardiovascular implants company with operations in India and Germany.

Commenting on the appointment, Himanshu Baid, Managing Director, Poly Medicure said, ” Poly Medicure stands at a pivotal point in its journey today. Over the years, we have built a strong foundation in medical devices and established a growing presence across global markets. As we continue to invest in innovation, expand our portfolio into higher-value segments, and strengthen our international footprint through strategic investments and acquisitions, it is important that we have the right leadership to guide this next phase of growth. Indranil brings deep industry expertise, global perspective, and a proven ability to build and scale businesses. His experience will be invaluable as we continue our journey towards becoming a globally recognised medtech leader.”

Commenting on his appointment, Indranil Mukherjee, Chief Executive Officer, Asia Pacific and India, Poly Medicure said, “Poly Medicure has built an exceptional platform over the years, combining strong manufacturing capabilities, a culture of innovation, and a growing presence across international markets. What particularly excites me is the Company’s ambition to move beyond scale and create greater value through differentiated technologies, deeper market engagement, and a sharper focus on global growth. As healthcare systems across the world seek reliable, high-quality medical device partners, Poly Medicure is uniquely positioned to capitalise on these opportunities. I look forward to working with the leadership team and the board to strengthen our presence across India and Asia Pacific, accelerate growth in strategic markets, and contribute to the Company’s long-term vision of becoming a globally recognised medical devices leader.”